Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...